168 related articles for article (PubMed ID: 10537294)
1. Effects of the antiestrogen EM-800 (SCH 57050) and cyclophosphamide alone and in combination on growth of human ZR-75-1 breast cancer xenografts in nude mice.
Gutman M; Couillard S; Labrie F; Candas B; Labrie C
Cancer Res; 1999 Oct; 59(20):5176-80. PubMed ID: 10537294
[TBL] [Abstract][Full Text] [Related]
2. Effect of combined treatment with the pure antiestrogen EM-800 and radiotherapy on the growth of human ZR-75-1 breast cancer xenografts in nude mice.
Couillard S; Gutman M; Labrie F; Candas B; Labrie C
Cancer Res; 1999 Oct; 59(19):4857-63. PubMed ID: 10519396
[TBL] [Abstract][Full Text] [Related]
3. Effect of treatment sequence with radiotherapy and the antiestrogen EM 800 on the growth of ZR 75 1 human mammary carcinoma in nude mice.
Gutman M; Couillard S; Labrie F; Candas B; Labrie C
Int J Cancer; 2003 Jan; 103(2):268-76. PubMed ID: 12455043
[TBL] [Abstract][Full Text] [Related]
4. Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts.
Couillard S; Labrie C; Bélanger A; Candas B; Pouliot F; Labrie F
J Natl Cancer Inst; 1998 May; 90(10):772-8. PubMed ID: 9605648
[TBL] [Abstract][Full Text] [Related]
5. Long-term inhibitory effect of the orally active and pure antiestrogen EM-800 on the growth of human breast cancer xenografts in nude mice.
Couillard S; Labrie C; Gauthier S; Merand Y; Singh SM; Candas B; Labrie F
Int J Cancer; 2000 Feb; 85(3):424-9. PubMed ID: 10652436
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of the antiestrogens EM-800 and tamoxifen on the growth of human breast ZR-75-1 cancer xenografts in nude mice.
Couillard S; Gutman M; Labrie C; Bélanger A; Candas B; Labrie F
Cancer Res; 1998 Jan; 58(1):60-4. PubMed ID: 9426058
[TBL] [Abstract][Full Text] [Related]
7. Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice.
Dauvois S; Geng CS; Lévesque C; Mérand Y; Labrie F
Cancer Res; 1991 Jun; 51(12):3131-5. PubMed ID: 2039992
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat.
Luo S; Sourla A; Labrie C; Bélanger A; Labrie F
Endocrinology; 1997 Oct; 138(10):4435-44. PubMed ID: 9322961
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
Li S; Lévesque C; Geng CS; Yan X; Labrie F
Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
Luo S; Stojanovic M; Labrie C; Labrie F
Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575
[TBL] [Abstract][Full Text] [Related]
11. Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050).
Luo S; Labrie C; Bélanger A; Candas B; Labrie F
Breast Cancer Res Treat; 1998 May; 49(1):1-11. PubMed ID: 9694606
[TBL] [Abstract][Full Text] [Related]
12. Effect of twenty-four-week treatment with the antiestrogen EM-800 on estrogen-sensitive parameters in intact and ovariectomized mice.
Luo S; Sourla A; Labrie C; Gauthier S; Merand Y; Belanger A; Labrie F
Endocrinology; 1998 May; 139(5):2645-56. PubMed ID: 9564882
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.
Gutman M; Couillard S; Roy J; Labrie F; Candas B; Labrie C
Int J Cancer; 2002 May; 99(2):273-8. PubMed ID: 11979444
[TBL] [Abstract][Full Text] [Related]
14. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium.
Labrie F; Labrie C; Bélanger A; Simard J; Gauthier S; Luu-The V; Mérand Y; Giguere V; Candas B; Luo S; Martel C; Singh SM; Fournier M; Coquet A; Richard V; Charbonneau R; Charpenet G; Tremblay A; Tremblay G; Cusan L; Veilleux R
J Steroid Biochem Mol Biol; 1999; 69(1-6):51-84. PubMed ID: 10418981
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouse.
Martel C; Labrie C; Bélanger A; Gauthier S; Mérand Y; Li X; Provencher L; Candas B; Labrie F
Endocrinology; 1998 May; 139(5):2486-92. PubMed ID: 9564862
[TBL] [Abstract][Full Text] [Related]
16. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
17. Long-term inhibitory effects of a novel anti-estrogen on the growth of ZR-75-1 and MCF-7 human breast cancer tumors in nude mice.
Luo S; Martel C; Gauthier S; Mérand Y; Bélanger A; Labrie C; Labrie F
Int J Cancer; 1997 Nov; 73(5):735-9. PubMed ID: 9398055
[TBL] [Abstract][Full Text] [Related]
18. Morphological changes induced by 6-month treatment of intact and ovariectomized mice with tamoxifen and the pure antiestrogen EM-800.
Sourla A; Luo S; Labrie C; Bélanger A; Labrie F
Endocrinology; 1997 Dec; 138(12):5605-17. PubMed ID: 9389549
[TBL] [Abstract][Full Text] [Related]
19. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
Robinson SP; Jordan VC
Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384.
Nishino Y; Schneider MR; Michna H
J Cancer Res Clin Oncol; 1994; 120(5):298-302. PubMed ID: 8126059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
